| |
| |
|
| Insider
Information: |
Santini Gino |
| Relationship: |
Director |
| City: |
Indianapolis |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
172,151 |
|
|
Indirect Shares
|
3,249 |
|
|
| Direct
Value |
$82,659,733 |
|
|
|
Indirect Value
|
$2,702,388 |
|
|
| Total
Shares |
175,400 |
|
|
| Total
Value |
$85,362,121 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eli Lilly & Co |
LLY |
Sr.VP, Corp. Strategy ... |
2009-12-07 |
96,495 |
2009-12-07 |
3,249 |
Premium* |
|
|
AMAG Pharmaceuticals Inc |
AMAG |
Director |
2020-11-16 |
0 |
2013-05-23 |
0 |
Premium* |
|
|
Collegium Pharmaceutical, Inc |
COLL |
Director |
2024-05-16 |
75,656 |
|
0 |
Premium* |
|
|
Horizon Pharma, Inc. |
HZNP |
Director |
2023-10-06 |
0 |
2023-10-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
83 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2017-05-03 |
4 |
D |
$15.12 |
$82,812 |
I/I |
(5,477) |
12,316 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Director |
– • – |
2017-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
4,545 |
19,510 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2018-05-03 |
4 |
D |
$13.87 |
$76,521 |
I/I |
(5,517) |
20,853 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2018-05-03 |
4 |
OE |
$0.00 |
$0 |
I/I |
14,054 |
26,370 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2018-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,253 |
25,441 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Director |
– • – |
2018-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,578 |
23,088 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2019-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,707 |
30,148 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2019-05-03 |
4 |
D |
$26.54 |
$159,612 |
I/I |
(6,014) |
30,159 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2019-05-03 |
4 |
OE |
$0.00 |
$0 |
I/I |
15,320 |
36,173 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Director |
– • – |
2019-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
8,116 |
31,204 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2020-05-02 |
4 |
OE |
$0.00 |
$0 |
I/I |
15,390 |
45,549 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2020-05-02 |
4 |
D |
$35.62 |
$215,180 |
I/I |
(6,041) |
39,508 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2020-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
4,047 |
34,195 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Director |
– • – |
2020-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10,269 |
41,473 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2020-08-03 |
4 |
OE |
$2.37 |
$103,262 |
D/D |
35,795 |
35,795 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Director |
– • – |
2020-11-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(41,473) |
0 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2021-03-01 |
4 |
S |
$91.47 |
$1,097,600 |
D/D |
(12,000) |
23,795 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2021-04-30 |
4 |
OE |
$0.00 |
$0 |
I/I |
11,098 |
50,606 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2021-04-30 |
4 |
D |
$94.62 |
$412,259 |
I/I |
(4,357) |
46,249 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
9,941 |
44,136 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2022-04-29 |
4 |
D |
$98.56 |
$163,412 |
I/I |
(1,658) |
48,814 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2022-04-29 |
4 |
OE |
$0.00 |
$0 |
I/I |
4,223 |
50,472 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2022-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
14,035 |
58,171 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
– • – |
2023-04-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,913 |
57,867 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2023-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
9,792 |
67,963 |
0 |
- |
|
83 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
